Pet medicines pose poison risk for kids

Medications/Drugs News Headlines - Yahoo! News

Pet medicines pose poison risk for kids

Children five and under account for 88 percent of calls to poison control centers for exposure to veterinary medicines, researchers report in Pediatrics. When children did go to a hospital or health facility, they were evaluated and treated or released in about 60 percent of cases.

more info...

Priced like an automaker, sputtering Gilead shares lure value bets

By Lewis Krauskopf NEW YORK (Reuters) - Shares of Gilead Sciences Inc are languishing over concerns about the U.S. biotechnology company's declining hepatitis C drugs and profit outlook, but some value investors sense an opportunity with shares at extremely cheap levels. On a price-to-earnings basis, commonly used to value stocks, Gilead shares are trading under 7 times earnings estimates for the next 12 months. One value investor, New York-based Matrix Asset Advisors, has been adding "pretty actively" to its Gilead position, said Chief Investment Officer David Katz.

more info...

Mylan agreed to pay $96.5 million in Provigil antitrust class action

The settlement was disclosed in a filing by the drug purchasers in Pennsylvania federal court on Friday, and must still be approved by the court. The money will go to purchasers that bought brand-name Provigil from Cephalon directly, like wholesalers and distributors.

more info...

Genes point to who develops lung disease, study finds

Scientists unveiled a trove of newly-discovered gene variants on Monday to help predict who will most likely develop a killer lung disease, both among smokers and non-smokers. The world's biggest probe of the genetics of lung health yielded 43 new gene variants linked to chronic obstructive pulmonary disease (COPD), a major cause of death. People with the wrong genetic makeup who also smoke are especially at risk, a team of scientists wrote in the journal Nature Genetics.

more info...